ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,699.94
0.00%
Dow Jones
42,011.59
0.00%
US Dollar vs MXN
19.3439
-0.03%
Brent Oil
78.075
0.35%
Bitcoin
61,753.91
1.65%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo:
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
04/10/202408:03Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
04/10/202408:02Business WirePeak Mobile Vascular Expands Services to the Midwest
04/10/202408:02Business WireBitwise Files To Convert Three Futures-Based ETFs to New “Trendwise” Strategies
04/10/202408:02PR Newswire (US)Schoox Honored in Training Industry's List of 'Top 20 LMS Companies' for a Third Consecutive Year
04/10/202408:01Business WireSkyWest, Inc. Announces Third Quarter 2024 Results Call DateNASDAQ:SKYWSkyWest Inc
04/10/202408:01PR Newswire (Canada)Métaux Russel conférence téléphonique - résultats du troisième trimestre 2024TSX:RUSRussel Metals Inc
04/10/202408:00GlobeNewswire Inc.Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual MeetingNASDAQ:CADLCandel Therapeutics Inc
04/10/202408:00Edgar (US Regulatory)Form 8-K - Current reportNYSE:UMH-DUMH Properties Inc
04/10/202408:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEHLAntelope Enterprise Holdings Ltd
04/10/202408:00GlobeNewswire Inc.NEXGEL Appoints Kip Crecca to its Scientific Advisory BoardNASDAQ:NXGLNexGel Inc
04/10/202408:00GlobeNewswire Inc.STMicroelectronics Announces Timing for Third Quarter 2024 Earnings Release and Conference Call and Capital Markets Day WebcastEU:STMPAST Microelectronics
04/10/202408:00GlobeNewswire Inc.SB Financial Group, Inc. Announces Schedule for Third Quarter 2024 ResultsNASDAQ:SBFGSB Finanical Group Inc
04/10/202408:00Business WireGrammarly Named an Emerging Leader in Gartner® “Emerging Market Quadrant for Generative AI Technologies”
04/10/202408:00Business WireClasp Therapeutics to Present Preclinical Data Evaluating Novel T Cell Engager Targeting p53 Mutant Solid Tumors
04/10/202408:00GlobeNewswire Inc.Immatics Announces Upcoming Oral and Poster Presentations at the Society for Immunotherapy of Cancer Annual Meeting 2024NASDAQ:IMTXImmatics NV
04/10/202408:00Business WireJanus Henderson to Report Third Quarter 2024 ResultsNYSE:JHGJanus Henderson Group Plc
04/10/202408:00Business WireFBFK Law Closes Acquisition Deal: IP Supplier Aragio Solutions Acquired by Faraday Technology
04/10/202408:00GlobeNewswire Inc.HotelPlanner partners with USA Archery’s Two National Collegiate Events, Collegiate Target Nationals and Collegiate 3D Nationals
04/10/202408:00GlobeNewswire Inc.Alpha Star Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Minimum Market Value DeficiencyNASDAQ:ALSAAlpha Star Acquisition Corporation
04/10/202408:00Business WireRealtime Robotics’ Optimization Solution Awarded Gold Merit Award for Technology in Robotics
04/10/202408:00Business WireCommunication Power Companies combines with Innovative Power Products, Inc.
04/10/202408:00Business WireMaxell Accelerating the Development of All-solid-state Batteries toward 2027
04/10/202408:00Business WireAbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024NASDAQ:ABCLAbCellera Biologics Inc
04/10/202408:00Business WireISG Announces 2024 ISG Paragon Awards™ North America WinnersNASDAQ:IIIInformation Services Group Inc
04/10/202408:00GlobeNewswire Inc.Nouscom to Present Updated Positive Data on NOUS-209’s Potential to ‘Intercept’ Cancer in Lynch Syndrome Carriers at SITC 2024
04/10/202408:00Business WireRPM General Counsel, Edward W. Moore, to Retire; Tracy D. Crandall Elected RPM General CounselNYSE:RPMRPM International Inc
04/10/202408:00GlobeNewswire Inc.Territorial Bancorp Postpones Special Meeting of StockholdersNASDAQ:HOPEHope Bancorp Inc
04/10/202408:00GlobeNewswire Inc.Roper Technologies schedules third quarter 2024 financial results conference callNASDAQ:ROPRoper Technologies Inc
04/10/202408:00Business WireInterface, Inc. to Host Third Quarter 2024 Results Conference Call on November 1, 2024NASDAQ:TILEInterface Inc
04/10/202408:00GlobeNewswire Inc.Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingNASDAQ:CUECue Biopharma Inc

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
AMEX
XLF
Financial Select Sector
NYSE
JPM
JP Morgan Chase
CCOM
US500
US 500
NYSE
AXP
American Express
SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
NASDAQ
AMZN
Amazon.com
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados